Visit the Beckman Coulter web site
Click on the advert above to visit the company web site

Product category: Particle size analysis equipment
News Release from: Beckman Coulter | Subject: CD136
Edited by the Laboratorytalk Editorial Team on 09 March 2006

Antibody identifies marker of epithelial
cells

Beckman Coulter introduces IOTestR CD136 (RON)-PE conjugated monoclonal antibody for the identification of a receptor protein kinase potentially involved in tumour development and growth

The CD136 antigen is the product of the recepteur d'origine nantais (RON) gene It is mainly expressed on cells of epithelial origin

The RON receptor belongs to a group of kinases that play important regulatory roles in normal tissue and can also be involved in cellular disorganization and alteration when overexpressed or mutated.

The new CD136 (RON) antibody from Beckman Coulter will be valuable in a range of basic and clinical research, and has been used in a number of recent and current cancer studies.

It will also be useful in pharmaceutical research on therapies designed to block the tumorigenic process.

The preformulated, standardised IOTest CD136 (RON)-PE monoclonal antibody is provided in 100-test vials and is the only directly conjugated monoclonal antibody on the market.

It can be used to assess RON expression on both normal and abnormal epithelial cells, recognizing proRON and RON, and the three known RON variants.

"This antigen marker is very important for the study of epithelial tumours," commented Michel Pagniez, cellular analysis product manager for Beckman Coulter.

"The successful blocking of this kinase could result in efficient cancer therapies".

CD136 (RON)-PE is approved for research use only. Request a free brochure from Beckman Coulter ...

Beckman Coulter: contact details and other news
Email this article to a colleague
Register for the free Laboratorytalk email newsletter
Laboratorytalk Home Page

Search the Pro-Talk network of sites

Visit the Beckman Coulter web site